Joint Filer Information
| Names: | Deerfield Mgmt III, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Private Design Fund III, L.P., Deerfield Special Situations Fund, L.P. |
| Address: | 780 Third Avenue, 37th Floor New York, NY 10017 |
| Designated Filer: | James E. Flynn |
| Issuer and Ticker Symbol: | Xeris Pharmaceuticals, Inc.[XERS] |
| Date of Event Requiring Statement: | January 23, 2019 |
The undersigned, Deerfield Mgmt III, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Private Design Fund III, L.P. and Deerfield Special Situations Fund, L.P. are jointly filing the attached Statement of Changes in Beneficial Ownership on Form 4 with James E. Flynn with respect to the beneficial ownership of securities of Xeris Pharmaceuticals, Inc.
Signatures:
DEERFIELD MGMT, L.P. By: J.E. Flynn Capital, LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
| DEERFIELD MGMT III, L.P. By: J.E. Flynn Capital III, LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
|
DEERFIELD MANAGEMENT COMPANY, L.P. By: Flynn Management LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
| DEERFIELD PRIVATE DESIGN FUND III, L.P. By: Deerfield Mgmt III, L.P., General Partner By: J.E. Flynn Capital III, LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
|
DEERFIELD SPECIAL SITUATIONS FUND, L.P. By: Deerfield Mgmt, L.P., General Partner By: J.E. Flynn Capital, LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact |